The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The EQUAL study: Utilizing plasma EGFR cfDNA detection as an accessible screening tool for lung cancer in underserved patients ineligible for routine screening.
 
Narjust Florez
Employment - Dana Farber Cancer Hospital
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Genentech; Janssen; Jazz Pharmaceuticals; Merck; Mirati Therapeutics; NeoGenomics Laboratories; Novocure; Nuvation Bio; Pfizer; Regeneron
Research Funding - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Genentech
Other Relationship - Clinical Care Options; CME Outfitters; CME Outfitters; IDEOlogy Health; Medscape; PER; Precisca
 
Lilin Tong
Employment - RA Capital (I)
 
Lauren Kiel
No Relationships to Disclose
 
Rebekah Kaufman
Employment - Dana-Farber Cancer Institute
Travel, Accommodations, Expenses - Dana-Farber Cancer Institute
 
Courtney Mantz
Employment - Boston Children's Hospital; Boston Children's Hospital (I); Dana Farber Cancer Hospital
Research Funding - Dana Farber Cancer Hospital
Travel, Accommodations, Expenses - Dana Farber Cancer Hospital
 
Jenna Beckwith
No Relationships to Disclose
 
Daniel Costa
Honoraria - Pfizer; Takeda/Millennium
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Included Health; Janssen Oncology; Takeda/Millennium; Teladoc
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Genentech (Inst); Merck (Inst); Merrimack (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst); Takeda/Millennium (Inst)
 
Olayinka Fakorede
No Relationships to Disclose
 
Tia Kauffman
Employment - Dana-Farber Cancer Institute; Kaiser Permanente (I)
 
Yanan Kuang
Employment - Novartis (I)
Stock and Other Ownership Interests - Novartis (I)
 
Shidong Xu
No Relationships to Disclose
 
Alys Malcolm
No Relationships to Disclose
 
Shail Maingi
Employment - Merck (I)
Stock and Other Ownership Interests - Merck (I)
Consulting or Advisory Role - Prime Oncology
Other Relationship - Gilead Sciences
 
Pedro Sanz-Altamira
Honoraria - Aptitude Health; Cardinal Health; Curio Science; Kura Oncology; MDoutlook; OMNI Health Media; Zetagen therapeutics
Consulting or Advisory Role - Aptitude Health; Cardinal Health; Curio Science; Kura Oncology; MDoutlook; OMNI Health Media; Zetagen Therapeutics
 
Sapna Syngal
Consulting or Advisory Role - Natera
Research Funding - Biological Dynamics
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute has a registered service mark for the PREMM5 model and holds copyrights for the PREMM questionnaires (Inst); Myriad Genetics (through Dana-Farber Cancer Institute) paid an inventor share of the IP (license issue fee)
Expert Testimony - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Pancreatic Cancer Action Network
 
Umit Tapan
Consulting or Advisory Role - American Journal of Managed Care; AstraZeneca; GlaxoSmithKline; JNJ
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; HMP; JNJ
 
Cam Anh Tran
No Relationships to Disclose
 
Lecia Sequist
Research Funding - AstraZeneca (Inst); Delfi Diagnostics (Inst); Novartis (Inst)
Other Relationship - GRAIL
 
Cloud Paweletz
No Relationships to Disclose
 
David Barbie
Stock and Other Ownership Interests - Medzown; Xsphera Biosciences
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo/UCB Japan; Gilead Sciences; Synthekine
Consulting or Advisory Role - Nerviano Medical Sciences; Qiagen/N of One
Research Funding - Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Gilead Sciences; Novartis
Patents, Royalties, Other Intellectual Property - DFCI patents on microfluidic culture and analysis of organotypic tumor spheroids